Croda Pharma (formerly Avanti Polar Lipids)

Snaith, United Kingdom
GMP Lipid Excipients Ionizable Lipids Helper Lipids PEG-Lipids Cholesterol LNP Formulation Services
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Croda Pharma (formerly Avanti Polar Lipids)

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Snaith, United Kingdom
Modalities
GMP Lipid Excipients, Ionizable Lipids, Helper Lipids, PEG-Lipids, Cholesterol, LNP Formulation Services
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Croda Pharma (formerly Avanti Polar Lipids)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesGMP Lipid Excipients, Ionizable Lipids, Helper Lipids, PEG-Lipids, Cholesterol, LNP Formulation Services
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (6 modalities)

Frequently Asked Questions About Croda Pharma (formerly Avanti Polar Lipids)

What is Croda Pharma (formerly Avanti Polar Lipids)'s CDMO Signal Score?
Croda Pharma (formerly Avanti Polar Lipids) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Croda Pharma (formerly Avanti Polar Lipids) for a manufacturing program?
Use the free AI matchmaker to compare Croda Pharma (formerly Avanti Polar Lipids) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
LNP Formulation Services CDMOs →